Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme
| dc.contributor.author | Watermeyer, Jean M | |
| dc.contributor.author | Kro¨ger, Wendy L | |
| dc.contributor.author | O’Neill, Hester G | |
| dc.contributor.author | Trevor Sewell, B | |
| dc.contributor.author | Sturrock, Edward D | |
| dc.date.accessioned | 2016-07-27T13:02:18Z | |
| dc.date.available | 2016-07-27T13:02:18Z | |
| dc.date.issued | 2008 | |
| dc.date.updated | 2016-07-27T12:59:22Z | |
| dc.description.abstract | Human angiotensin-converting enzyme (ACE) has two homologous domains, the N and C domains, with differing substrate preferences. X-ray crystal structures of the C and N domains complexed with various inhibitors have allowed identification of active site residues that might be important for the molecular basis of this selectivity. However, it is unclear to what extent the different residues contribute to substrate domain selectivity. Here, cocrystal structures of human testis ACE, equivalent to the C domain, have been determined with two novel C domain-selective ketomethylene inhibitors, (5S)-5-[(Nbenzoyl)amino]-4-oxo-6-phenylhexanoyl-L-tryptophan (kAW) and (5S)-5-[(N-benzoyl)amino]-4-oxo-6- phenylhexanoyl-L-phenylalanine (kAF). The ketone groups of both inhibitors bind to the zinc ion as a hydrated geminal diolate, demonstrating the ability of the active site to catalyze the formation of the transition state. Moreover, active site residues involved in inhibitor binding have been mutated to their N domain counterparts, and the effect of the mutations on inhibitor binding has been determined. The C domain selectivity of these inhibitors was found to result from interactions between bulky hydrophobic side chain moieties and C domain-specific residues F391, V518, E376, and V380 (numbering of testis ACE). Mutation of these residues decreased the affinity for the inhibitors 4-20-fold. T282, V379, E403, D453, and S516 did not contribute individually to C domain-selective inhibitor binding. Further domainselective inhibitor design should focus on increasing both the affinity and selectivity of the side chain moieties. | en_ZA |
| dc.identifier | http://dx.doi.org/10.1021/bi8002605 | |
| dc.identifier.apacitation | Watermeyer, J. M., , , Trevor Sewell, B., & Sturrock, E. D. (2008). Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme. <i>Biochemistry</i>, http://hdl.handle.net/11427/20896 | en_ZA |
| dc.identifier.chicagocitation | Watermeyer, Jean M, , , B Trevor Sewell, and Edward D Sturrock "Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme." <i>Biochemistry</i> (2008) http://hdl.handle.net/11427/20896 | en_ZA |
| dc.identifier.citation | Watermeyer, J. M., Kröger, W. L., O’Neill, H. G., Sewell, B. T., & Sturrock, E. D. (2008). Probing the Basis of Domain-Dependent Inhibition Using Novel Ketone Inhibitors of Angiotensin-Converting Enzyme†‡. Biochemistry, 47(22), 5942-5950. | en_ZA |
| dc.identifier.issn | 1520-4995 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Watermeyer, Jean M AU - Kro¨ger, Wendy L AU - O’Neill, Hester G AU - Trevor Sewell, B AU - Sturrock, Edward D AB - Human angiotensin-converting enzyme (ACE) has two homologous domains, the N and C domains, with differing substrate preferences. X-ray crystal structures of the C and N domains complexed with various inhibitors have allowed identification of active site residues that might be important for the molecular basis of this selectivity. However, it is unclear to what extent the different residues contribute to substrate domain selectivity. Here, cocrystal structures of human testis ACE, equivalent to the C domain, have been determined with two novel C domain-selective ketomethylene inhibitors, (5S)-5-[(Nbenzoyl)amino]-4-oxo-6-phenylhexanoyl-L-tryptophan (kAW) and (5S)-5-[(N-benzoyl)amino]-4-oxo-6- phenylhexanoyl-L-phenylalanine (kAF). The ketone groups of both inhibitors bind to the zinc ion as a hydrated geminal diolate, demonstrating the ability of the active site to catalyze the formation of the transition state. Moreover, active site residues involved in inhibitor binding have been mutated to their N domain counterparts, and the effect of the mutations on inhibitor binding has been determined. The C domain selectivity of these inhibitors was found to result from interactions between bulky hydrophobic side chain moieties and C domain-specific residues F391, V518, E376, and V380 (numbering of testis ACE). Mutation of these residues decreased the affinity for the inhibitors 4-20-fold. T282, V379, E403, D453, and S516 did not contribute individually to C domain-selective inhibitor binding. Further domainselective inhibitor design should focus on increasing both the affinity and selectivity of the side chain moieties. DA - 2008 DB - OpenUCT DP - University of Cape Town J1 - Biochemistry LK - https://open.uct.ac.za PB - University of Cape Town PY - 2008 SM - 1520-4995 T1 - Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme TI - Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme UR - http://hdl.handle.net/11427/20896 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/20896 | |
| dc.identifier.uri | http://pubs.acs.org/doi/abs/10.1021/bi8002605 | |
| dc.identifier.vancouvercitation | Watermeyer JM, , , Trevor Sewell B, Sturrock ED. Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme. Biochemistry. 2008; http://hdl.handle.net/11427/20896. | en_ZA |
| dc.language | eng | en_ZA |
| dc.publisher | ACS Publications | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.source | Biochemistry | en_ZA |
| dc.source.uri | http://pubs.acs.org/journal/bichaw | |
| dc.subject.other | Domain-Dependent Inhibition | |
| dc.subject.other | Novel Ketone Inhibitors | |
| dc.subject.other | Angiotensin-Converting Enzyme | |
| dc.title | Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |